Iradimed (IRMD) Non-Current Assets (2013 - 2026)

Iradimed (IRMD) has reported Non-Current Assets for 14 consecutive years, with $28.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 2.83% year-over-year to $28.3 million in Q2 2026; TTM through Jun 2026 was $113.6 million, a 15.08% increase from a year earlier, with the FY2025 full-year figure at $27.6 million, up 19.45% from the prior year.
• Non-Current Assets was $28.3 million for Q2 2026 at Iradimed, up from $28.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $29.8 million in Q3 2025 and troughed at $6.9 million in Q1 2022.
• A 5-year average of $18.7 million and a median of $16.3 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets soared 112.21% in 2023 and declined 2.83% in 2026, its largest moves.
• Over 5 years, Non-Current Assets stood at $8.0 million in 2022, then jumped by 101.33% to $16.2 million in 2023, then surged by 42.89% to $23.1 million in 2024, then increased by 19.45% to $27.6 million in 2025, then grew by 2.47% to $28.3 million in 2026.
• The last three Non-Current Assets figures came in at $28.3 million (Q2 2026), $28.0 million (Q1 2026), and $27.6 million (Q4 2025), per Business Quant data.